System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Enora Laas is an expert in Oncology at Institut Curie (France). As of October 2026, ScienceLeadR ranks Enora Laas in the top 1% of experts worldwide for Breast Neoplasms and Breast Diseases. Enora Laas has authored 197 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 4 of them ongoing. SLR score: 677 (community average: 125). How the SLR is computed.

LeadR Profile

Enora Laas Institut Curie France
677 ScienceLeadR Reputation 677

Unlock

Register Login
Network Map

Oncology

Subspecialties: Gynecology - Surgery - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026
Source: PubMed

Institut Curie

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 197

Citations

Citations: 2 175 1st author: 36 Last author: 11 Unique author: 0

Main journals

Int J Gynecol Cancer 15
Cancer Res 13
Cancers (Basel) 13
Ann Surg Oncol 9
Bull Cancer 8

Best Journals

J Clin Oncol 6
Ann Oncol 3
Nat Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
ASO Visual Abstract: Impact of Tumor Size on Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
PMID 42686944 — breast neoplasms, neoplasms, drug therapy, breast, chemotherapy		Ann Surg Oncol20260
Impact of Tumor Size on Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
PMID 42627610 — breast neoplasms, neoplasms, drug therapy, breast, neoadjuvant therapy, therapeutics, chemotherapy		Ann Surg Oncol20260
Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence.
PMID 42584500 — skin, breast neoplasms, incidence, neoplasms, breast		Breast Cancer Res Treat20260
Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy.
PMID 42531804 — triple negative breast neoplasms, circulating tumor dna, breast neoplasms, neoplasms, biomarkers, neoplasm metastasis, breast, neoadjuvant therapy, therapeutics, dna, plasma		ESMO Open20261
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.
PMID 42411723 — cytoreduction surgical procedures, ovary, neoplasms, ovarian neoplasms		J Gynecol Oncol20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 3 3
Phase 2 1

By status:

Recruiting 4
Active not recruiting 1
Completed 1
Not yet recruiting 1
Terminated 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 2
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53 Mutated Endometrial Cancer A Non Inferiority Randomized Trial
NCT06900582 — genes, lymph nodes, lymph node excision, ureter, neoplasms, sentinel lymph node, biopsy, arteries, genes, p53, lymph, tissues, ligaments, sentinel lymph node biopsy, indocyanine green, anatomy, iliac artery, mutation, dissection, endometrial neoplasms, cervix uteri		N/ANot yet recruiting2026
Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer
NCT06416748 — margins of excision, minimally invasive surgical procedures, lymph nodes, conization, hysterectomy, uterine cervical neoplasms, neoplasms, sentinel lymph node, biopsy, laparoscopy, algorithms, lymph, therapeutics, sentinel lymph node biopsy, cervix uteri		N/ARecruiting2024
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma		Phase 3Recruiting2023
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
NCT04666961 — anastrozole, mastectomy, breast neoplasms, carcinoma, ductal, neoplasms, hormones, carcinoma, intraductal, noninfiltrating, breast, therapeutics, tamoxifen, carcinoma in situ, carcinoma		Phase 2Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS